Group items tagged

The industry report Footwear Market in China to 2017 offers the most up-to-date perspective on the actual market situation, trends, and future outlook for footwear in China. This study includes historic market data from 2006 to 2012 and forecasts until 2017 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key market insights in a readily accessible and clearly presented format.

This report provides the results for the Soy Products market in China from Canadeans unique, highly detailed study of consumers Consumer Packaged Goods (CPG) consumption habits, and forms part of an overall series covering all CPG product markets. Its coverage includes, but is not limited to, consumption behaviors, the extent to which consumer trends influence their consumption, the value of the market these trends influence, and brand and private label choices as well as retailer choices.

2015 Global Retinoblastoma Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Retinoblastoma Drugs industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

India, Brazil, the Middle East, and China were projected to be the important emerging markets in the global power industry to offer growth in 2013. Market uncertainty, rising competition, regulatory changes, and responding to pricing pressure remained to be the leading business concerns for the global power industry in 2013. Price, level of service and delivery lead times is considered to be the most important factors for supplier selection in the global power industry. On the other hand, brand reputation, environmental records and CSR are considered the least important. Survey results showed that respondents from the global power industry identified Singapore, Taiwan, Hong Kong, the US, and Australia to offer the highest growth potential among developed countries during 2013 and 2014.

Rising competition, retention or recruitment of skilled staff, market uncertainty, and responding to pricing pressure were the leading business concerns for the global oil and gas industry in 2013. Middle East, Brazil, India, China and Indonesia were forecasted to be the important emerging markets to offer growth in 2013. Capital expenditure towards facility expansion, machinery and equipment purchase and new product development was estimated to increase in 2013. The top three priorities for global oil and gas industry upstream oil and gas companies in 2013 were to expand in current market, improve operational efficiency and focus on sustainability.

India and China are the major emerging contributors to Asia-Pacific's mass affluent population growth. Insights about the mass affluent banking market in addition to the spending behavior of the mass affluent with an emphasis on the banking sector offers a perspective on the key factors that are driving and generating new opportunities for the mass affluent market. Europe has the largest mass affluent population, while Asia-Pacific's is the fastest-growing.

Saudi Arabia is estimated to have the fourth largest defense budget in the world, behind the US, China, and Russia. Valued at USD 52.9 billion in 2013, the country's defense expenditure is at the seventh position among the top 10 military spenders. An underdeveloped domestic defense industry coupled with the country's high spending power makes the competitive landscape for Saudi Arabian defense favorable presenting ample opportunities for foreign OEMs to enter the market through an alliance route.

China, India and Brazil emerged as the most important markets in the construction industry in 2013. A construction market analysis revealed that market uncertainty, cost containments and retention and recruitment of skilled staff were the major concerns hindering the construction industry growth for 2013. Construction industry statistics reveal that the average size of the annual procurement budget was projected at USD 41 million, while the annual marketing budget was identified at USD 6 million in 2013. The future product investment areas unveil emerging opportunities attracting competition.

According to market forecasts, the global renal denervation market will witness significant growth over the next six years, jumping from USD 15.5 million in 2012 to USD 171.7 million by 2019, at a CAGR of 41%. This will mainly be attributable to the intervention's expected approval in major countries. It is stated that across 10 major markets in the major global economies (the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India), only the European Union has approved the use of renal denervation.